IAC says Boeing crashed outside Bishkek was in good technical conditionWorld January 24, 14:24
Syria ceasefire monitoring mechanism may be included in separate document — sourceWorld January 24, 14:11
Italian top diplomat urges EU and US to solve sanctions issue togetherWorld January 24, 14:06
World athletics body to give timeframe for admitting Russian athletes to competitionsSport January 24, 13:36
Analyst believes China’s missiles near Russian borders targeted against USRussian Politics & Diplomacy January 24, 13:14
Russia, Turkey agree to continue work with Syrian participants in Astana meetingRussian Politics & Diplomacy January 24, 13:07
Press review: Syria peace talks in Astana and Hungary's losses from anti-Russian sanctionsPress Review January 24, 13:00
Source claims Russia, Iran and Turkey agree on mechanism to monitor Syria ceasefireWorld January 24, 12:47
Kremlin refuses to comment on Astana talks as process is ‘in full swing’Russian Politics & Diplomacy January 24, 12:32
MOSCOW, October 10 (Itar-Tass) — Russia’s ex-finance minister Alexei Kudrin insists that the country should invest more money into healthcare and less into defence.
“Russia still has to go down the path of increasing expenditures on healthcare. In this respect I would inject less into military needs than into healthcare,” he told the forum dealing with the Sixth Millennium Development Goal MDG-6 that opened in Moscow on Monday.
He reiterated his position saying that “an increase in military spending poses a threat to the support and development of healthcare and education programs.” “This is the reason of my conflict with the Russian incumbent president.”
In late September Alexei Kudrin resigned after a disagreement with President Dmitry Medvedev’s economic policy targeted at increasing expenditures on defence.
Speaking about reaching the development goals, mainly the goal to combat HIV/AIDS, malaria and other diseases, Kudrin stressed the need for creating a mechanism that would attract large pharmaceutical corporations to work in less developed countries and for the poor, as well-to-do people have access to most state-of-the-art medicines.